Qualitative and Quantitative Analysis of Tryptamines in the Poison of Incilius alvarius (Amphibia: Bufonidae).
Schwelm HM, Zimmermann N, Scholl T, Penner J, Autret A, Auwärter V, Neukamm MA.
J Anal Toxicol · journal article · DOI 10.1093/jat/bkab038 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för 5-methoxy-N,N-dimethyltryptamine. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
17 träffarUse of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects.
Lancelotta RL, Davis AK.
J Psychoactive Drugs · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1080/02791072.2020.1737763Anxiety-like behavior induced by salicylate depends on age and can be prevented by a single dose of 5-MeO-DMT.
Winne J, Boerner BC, Malfatti T, Brisa E, Doerl J, Nogueira I, Leão KE, Leão RN.
Exp Neurol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.expneurol.2020.113175Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.
Uthaug MV, Lancelotta R, Szabo A, Davis AK, Riba J, Ramaekers JG.
Psychopharmacology (Berl) · research-article; journal article; observational study · DOI 10.1007/s00213-019-05414-wA single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.
Uthaug MV, Lancelotta R, van Oorsouw K, Kuypers KPC, Mason N, Rak J, Šuláková A, Jurok R, Maryška M, Kuchař M, Páleníček T, Riba J, Ramaekers JG.
Psychopharmacology (Berl) · research-article; journal article; observational study · DOI 10.1007/s00213-019-05236-wCorrigendum: A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus.
Lima da Cruz RV, Moulin TC, Petiz LL, Leão RN.
Front Mol Neurosci · published erratum; correction; journal article · DOI 10.3389/fnmol.2019.000795-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety.
Davis AK, So S, Lancelotta R, Barsuglia JP, Griffiths RR.
Am J Drug Alcohol Abuse · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1080/00952990.2018.1545024Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.
Barsuglia J, Davis AK, Palmer R, Lancelotta R, Windham-Herman AM, Peterson K, Polanco M, Grant R, Griffiths RR.
Front Psychol · research-article; journal article · DOI 10.3389/fpsyg.2018.02459A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder.
Barsuglia JP, Polanco M, Palmer R, Malcolm BJ, Kelmendi B, Calvey T.
Prog Brain Res · research support, non-u.s. gov't; journal article · DOI 10.1016/bs.pbr.2018.08.002A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus.
Lima da Cruz RV, Moulin TC, Petiz LL, Leão RN.
Front Mol Neurosci · research-article; journal article · DOI 10.3389/fnmol.2018.00312The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption.
Davis AK, Barsuglia JP, Lancelotta R, Grant RM, Renn E.
J Psychopharmacol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1177/0269881118769063Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT.
Dakic V, Minardi Nascimento J, Costa Sartore R, Maciel RM, de Araujo DB, Ribeiro S, Martins-de-Souza D, Rehen SK.
Sci Rep · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41598-017-12779-5The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT(1A) and 5-HT(2A) receptors.
Riga MS, Bortolozzi A, Campa L, Artigas F, Celada P.
Neuropharmacology · journal article · DOI 10.1016/j.neuropharm.2015.10.016Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.
Jiang XL, Shen HW, Yu AM.
Neuropharmacology · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.neuropharm.2014.10.013The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs.
Riga MS, Soria G, Tudela R, Artigas F, Celada P.
Int J Neuropsychopharmacol · research support, non-u.s. gov't; journal article · DOI 10.1017/s14611457140002615-HT1A receptor activation is necessary for 5-MeODMT-dependent potentiation of feeding inhibition.
Duvvuri V, Risbrough VB, Kaye WH, Geyer MA.
Pharmacol Biochem Behav · research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1016/j.pbb.2009.05.014Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS.
Forsström T, Tuominen J, Karkkäinen J.
Scand J Clin Lab Invest · research support, non-u.s. gov't; journal article · DOI 10.1080/003655101753218319